Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Monte Rosa Therapeutics (GLUE) Drug Pipeline

408 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Apalutamide, Oral Mrt-2359Prostate Cancer, Castration-Resistant Prostate Cancer (Crpc), Castration-Resistant Prostate Cancer, Prostate Cancer (Adenocarcinoma)Phase IIRecruitingStudy of Oral MRT-2359 With Apalutamide in Prostate CancerJul 29, 2026―
Mrt-8102Elevated Crp, Healthy VolunteersPhase IActive Not RecruitingA First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRPJul 30, 2025
Mrt-6160Healthy VolunteersPhase ICompletedFirst-in-human Study of MRT-6160 in Healthy SubjectsAug 02, 2024―
Oral Mrt-2359Sclc, Prostate Cancer, Dlbcl, Nsclc, High Grade Neuroendocrine Cancer, L-Myc And N-Myc Amplified Solid Tumors, Nsclc With High Or Low L-Myc Or N-Myc Expression, Hr-Positive, Her2-Negative Breast Cancerphase1AndPhase2RecruitingStudy of Oral MRT-2359 in Selected Cancer PatientsSep 16, 2022

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Monte Rosa Therapeutics, Inc. (GLUE) have in its pipeline
Monte Rosa Therapeutics GLUE is currently developing the following drugs: Apalutamide, Oral Mrt-2359, Mrt-8102, Mrt-6160, Oral Mrt-2359. These drug candidates are in various stages of clinical development as the company works toward FDA approval.